Clinical microbiological studies evaluating the reduction of MRSA and C. diff transmission following automated robot disinfection.
Healthcare-associated infections afflict 1 in 31 hospital patients in the United States, causing tens of thousands of deaths and billions of dollars in unreimbursed treatment costs annually.
Manual wiping with chemical disinfectants is notoriously inconsistent: audits show cleaning staff miss up to 50% of high-touch room surfaces, and chemical dwell times are frequently violated.
Peer-reviewed clinical trials demonstrate that deploying autonomous UV-C robots for terminal room cleaning reduces hospital-wide Clostridioides difficile and VRE acquisition rates by over 35% compared to manual cleaning alone.